Cardiac Monitoring & Cardiac Rhythm Management Devices Market By Product CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User - Global Forecasts to 2025
Inquire Now to get the global numbers on Cardiac Monitoring Devices Market
The global cardiac monitoring devices market in terms of revenue was estimated to be worth $22.1 billion in 2020 and is poised to reach $26.8 billion by 2025, growing at a CAGR of 4.0% from 2020 to 2025. The emerging economies such as India and China are expected to provide a wide range of growth opportunities for players in the market which is driven by their large and growing populations as well as the increasing number of hospitals and clinics in these countries.
To know about the assumptions considered for the study, Request for Free Sample Report
Cardiac Monitoring Devices Market Dynamics
DRIVERS: Rising prevalence of cardiovascular disease
Cardiovascular disease (CVD) is the leading cause of death worldwide. According to the World Health Organization (WHO), CVD is the major cause of death globally, and approximately 30 million people suffer heart attack or stroke annually. According to the American Heart Association, nearly half of the adults in the US have some type of CVD. By 2035, more than 130 million adults or 45.1% of the US population are projected to have some form of CVD.
Some of the primary risk factors for CVD include family history, ethnicity, and age. Other risk factors include tobacco consumption, high blood pressure (hypertension), high cholesterol, obesity, physical inactivity, diabetes, unhealthy diets, and consumption of alcohol. Due to lifestyle changes, there has been an increase in the incidence of diseases such as hypertension, diabetes, dyslipidemia, and obesity, which also contribute to the rising incidence of CVD across the globe.
Most types of CVDs can be prevented through pre-monitoring and pre-diagnosis. Likewise, abnormalities in the functioning of the heart, called arrhythmias, can be averted with early diagnosis. Owing to this, the demand for CM & CRM devices is increasing as these devices help save patients at high risk of cardiac arrest.
BURNING ISSUES: Risk of associated cybersecurity vulnerabilities
Cyber-security vulnerabilities in medical devices, mainly devices such as CIEDs, where the potential for reprogramming or rendering the device nonfunctional exists, is a key area of concern among patients and healthcare providers.
According to an alert issued by the Homeland Security Department during 2019, as many as 750,000 heart devices made by Medtronic PLC contained a serious cybersecurity vulnerability that could let an attacker with sophisticated insider knowledge harm a patient by altering programming on an implanted defibrillator. In 2017, nearly 500,000 implantable pacemakers were recalled by the US Food and Drug Administration (FDA) due to their potential vulnerability to hacking. Hence, limiting the growth of the market to a certain extent.
OPPORTUNITIES: Measures to reduce infections caused due to CIEDs
CIEDs are associated with an increase in survival and quality of life while treating cardiac arrhythmias. However, CIED-associated infections are a major complication associated with the use of these devices. CIED infections most commonly occur in patients with an implantable cardioverter defibrillator device or cardiac resynchronization therapy defibrillator device. According to the European Heart Journal, the incidence of CIED infections was 1.19% for pacemakers, 1.91% for implantable cardioverter-defibrillators, 2.18% for cardiac resynchronization therapy pacemakers (CRT-Ps), and 3.35% for CRT defibrillators (CRTDs).
Medtronic offers an absorbable, multifilament mesh envelope (TYRX Absorbable Antibacterial Envelope) to improve CIED stabilization in the subcutaneous pocket and to elute the antibiotics minocycline and rifampin. These envelopes are designed for use with cardiac implantable electronic devices (CIEDs), such as implantable cardioverter defibrillators (ICDs) and pacemakers. In 2019, results of an international randomized controlled trial showed that the envelope reduced the incidence of infection by 40%, compared to standard-of-care infection prevention alone.
ECG Devices is expected to hold the largest share of the cardiac monitoring devices market in 2020
On the basis of cardiac monitoring devices by type, the market is segmented into ECG devices, event monitors, implantable loop recorders (ILRs), cardiac output monitoring (COM) devices, mobile cardiac telemetry (MCT) devices, and smart ECG monitors. In 2019, the ECG devices segment accounted for the largest share of the cardiac monitoring devices market. The large share of this segment can be attributed to technological advancements such as the incorporation of advanced algorithms and workflow improvement features, such as simplified operations, touchscreen systems, portability, wireless features, and better connectivity with cardiovascular information systems (CVIS), electronic medical records (EMRs), and ECG management systems.
Defibrillators is expected to hold the largest share of the cardiac rhythm management devices market in 2020
On the basis of cardiac rhythm management devices by type, the market is segmented into defibrillators and pacemakers. In 2019, the defibrillators segment accounted for the largest market share. This segment is also projected to register the highest CAGR during the forecast period. Factors such as technological advancements in defibrillators, rising prevalence of CVD, and growing focus on providing public-access https://www.marketsandmarkets.com/Market-Reports/automated-external-defibrillator-market-549.htmldefibrillators are driving the growth of this market.
Hospitals segment commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2020
By end user, the cardiac monitoring & cardiac rhythm management devices market is segmented into hospitals; clinics, cardiac centers, and ambulatory surgery centers (ASCs); and other end users. Hospitals accounted for the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2019. The large share of this segment can be attributed to factors such as the increasing prevalence of CVD, the growing number of patient visits to hospitals for diagnosis, increasing number of cardiac implant procedures, and the availability of reimbursement for these procedures across developed markets.
To know about the assumptions considered for the study, download the pdf brochure
North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2020.
On the basis of region, the cardiac monitoring & cardiac rhythm management devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.
The major players operating in the cardiac monitoring & cardiac rhythm management devices market include Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER AG (Switzerland), BioTelemetry (US), BPL Medical Technologies (India), ACS Diagnostics (US), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical Technology (China), Shree Pacetronix (India), OSYPKA (Germany), and BTL t(US), Alivecor, Inc. (US), Amiitalia (Italy), Bexen Cardio (Spain), Narang Medical Limited (India), MeTrax GmbH (Germany), and Progetti Srl (Italy).
Cardiac Monitoring Devices Market Report Scope:
|
Report Metric |
Details |
|
Market Size Available for Years |
2016–2025 |
|
Base Year Considered |
2019 |
|
Forecast Period |
2020–2025 |
|
Forecast Units |
Value (USD) |
|
Segments Covered |
By cardiac monitoring devices by type, cardiac rhythm monitoring devices by type, end user, and region |
|
Geographies Covered |
North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), APAC (Japan, China, India, and the RoAPAC), and Rest of the World. |
|
Companies Covered |
Medtronic (Ireland), Boston Scientific (US), Abbott Laboratories (US), GE Healthcare (US), BIOTRONIK (Germany), and Koninklijke Philips (Netherlands), Asahi Kasei Corporation (Japan), MicroPort Scientific Corporation (China), Hill-Rom Holdings (US), Nihon Kohden (Japan), SCHILLER AG (Switzerland), BioTelemetry (US), BPL Medical Technologies (India), ACS Diagnostics (US), Shenzhen Mindray Bio-Medical Electronics (China), Lepu Medical Technology (China), Shree Pacetronix (India), OSYPKA (Germany), and BTL t(US), Alivecor, Inc. (US), Amiitalia (Italy), Bexen Cardio (Spain), Narang Medical Limited (India), MeTrax GmbH (Germany), and Progetti Srl (Italy). |
This research report categorizes the cardiac monitoring & cardiac rhythm management devices market into the following segments and sub-segments:
By Type
-
ECG Devices
- Resting ECG Devices
- Stress ECG Devices
- Holter Monitors
- Implantable Loop Recorders
- Mobile Cardiac Telemetry Devices
- Cardiac Output Monitoring Devices
-
Event Monitors
-
Event Monitors Market, by Type
- Pre-symptom Event Monitors
- Post-symptom Event Monitors
-
Event Monitors Market, by Technology
- Autodetect Monitors
- Manual Event Monitors
- Smart ECG Monitors
-
Event Monitors Market, by Type
By Type
-
Defibrillators
-
Implantable Cardioverter Defibrillators
-
Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
- Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators
- Dual-Chamber Implantable Cardioverter Defibrillators
- Single-Chamber Implantable Cardioverter Defibrillators
- Subcutaneous Implantable Cardioverter Defibrillators (T-ICDs)
-
Transvenous Implantable Cardioverter Defibrillators (T-ICDs)
-
External Defibrillators
-
Automated External Defibrillators
- Semi-Automated External Defibrillators
- Fully Automated External Defibrillators
- Manual External Defibrillators
- Wearable Cardioverter Defibrillators
-
Automated External Defibrillators
-
Pacemakers
-
Pacemakers Market, By Implantability
- Implantable Pacemakers
- External Pacemakers
-
Pacemakers Market, By Type
- Dual-Chamber Pacemakers
- Single-Chamber Pacemakers
- Biventricular/Crt Pacemakers
-
Pacemakers Market, By Implantability
-
Implantable Cardioverter Defibrillators
By End User
- Hospitals
- Clinics, Cardiac Centers and Ambulatory Surgery Centers
- Other End Users
By Region
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Key developments:
- In 2020, Abbott Laboratories launched Gallant implantable cardioverter defibrillator (ICD) in Europe.
- In 2019, ZOLL Medical (an Asahi Kasei Group Company) acquired Cardiac Science, a leading provider of automated external defibrillators (AEDs), related services, and accessories. This acquisition strengthened ZOLL Medical’s position in the AED segment.
- In 2018, BIOTRONIK has become the exclusive US distributor for InfoBionic’s MoMe Kardia external cardiac diagnostic monitor. This has helped the company expand its product portfolio of cardiovascular solutions to support physicians in providing the best care as fast and efficiently as possible.
- In 2017, Nihon Kohden opened a sales branch in Kenya. This initiative has helped the company to hold a strong customer base in the Middle East and Africa region.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 40)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 LIMITATIONS OF THE CURRENT EDITION
2 RESEARCH METHODOLOGY (Page No. - 45)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS
2.3 MARKET SIZE ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH CRM DEVICES MARKET
2.3.2 GROWTH FORECAST
2.3.3 TOP-DOWN APPROACH
FIGURE 5 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 MARKET DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 54)
FIGURE 7 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET
4 PREMIUM INSIGHTS (Page No. - 57)
4.1 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OVERVIEW
FIGURE 11 INCREASING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE AND COUNTRY (2019)
FIGURE 12 DEFIBRILLATORS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
4.3 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 13 CHINA TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 60)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 14 CM & CRM DEVICES MARKET: DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of cardiovascular disease
FIGURE 15 INCIDENCE OF CVD, BY REGION, 2017
5.2.1.2 Availability of reimbursement for CM & CRM devices
TABLE 1 CPT CODES FOR CM & CRM DEVICES, 2020
5.2.1.3 Launch of innovative products by market players
TABLE 2 RECENT PRODUCT LAUNCHES IN THE CM & CRM DEVICES MARKET
5.2.1.4 Increasing investments, funds, and grants for research on CM & CRM devices
5.2.1.5 Growing preference for wearable cardiac devices
5.2.2 RESTRAINTS
5.2.2.1 Frequent product recalls
TABLE 3 KEY PRODUCT RECALLS
5.2.3 CHALLENGES
5.2.3.1 Risk of associated cybersecurity vulnerabilities
5.2.3.2 Stringent regulatory requirements delaying the approval of cardiac devices
5.2.3.3 Dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices
5.2.4 OPPORTUNITIES
5.2.4.1 Measures to reduce infections caused due to CIEDs
5.3 VALUE CHAIN ANALYSIS
FIGURE 16 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
FIGURE 17 DIRECT DISTRIBUTION-THE PREFERRED STRATEGY FOR PROMINENT COMPANIES
5.4 ECOSYSTEM ANALYSIS
FIGURE 18 ECOSYSTEM ANALYSIS OF THE CARDIOVASCULAR DEVICES MARKET
5.5 AVERAGE SELLING PRICE TREND
FIGURE 19 AVERAGE PRICE FOR ECG DEVICES, 2019 VS. 2022 VS. 2025 (USD/UNIT)
5.5.1 COVID-19 IMPACT ON THE CM & CRM DEVICES MARKET
6 CARDIAC MONITORING DEVICES MARKET, BY TYPE (Page No. - 72)
6.1 INTRODUCTION
TABLE 4 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 5 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 6 ECG DEVICES & EVENT MONITORS MARKET, BY TYPE, 2018-2025 (UNITS)
6.2 ECG DEVICES
TABLE 7 ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 8 ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 9 ECG DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 10 ECG DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.2.1 RESTING ECG DEVICES
6.2.1.1 Low cost, ease of use, and simplicity have driven the adoption of resting ECG devices
TABLE 11 RESTING ECG DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 12 RESTING ECG DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.2.2 STRESS ECG DEVICES
6.2.2.1 Their flexibility of use has driven the demand for stress ECG devices, but high cost has negatively affected the market
TABLE 13 STRESS ECG DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 14 STRESS ECG DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.2.3 HOLTER MONITORS
6.2.3.1 Short duration of monitoring is a key restraint to market growth
TABLE 15 HOLTER MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 16 HOLTER MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.3 IMPLANTABLE LOOP RECORDERS
6.3.1 HIGH COST AND LIMITED APPLICATIONS HAVE HINDERED DEMAND GROWTH
TABLE 17 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 18 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.4 MOBILE CARDIAC TELEMETRY DEVICES
6.4.1 INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS IS PROPELLING MARKET GROWTH
TABLE 19 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 20 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.5 CARDIAC OUTPUT MONITORING DEVICES
6.5.1 INCREASING NUMBER OF CARDIAC SURGERIES WILL DRIVE THE DEMAND FOR COM DEVICES
TABLE 21 TYPES OF COM DEVICES
TABLE 22 CARDIAC OUTPUT MONITORING DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 23 CARDIAC OUTPUT MONITORING DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
6.6 EVENT MONITORS
TABLE 24 EVENT MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 25 EVENT MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.6.1 EVENT MONITORS MARKET, BY TYPE
TABLE 26 EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 27 EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
6.6.1.1 Pre-symptom event monitors
6.6.1.1.1 Large storage capacity of pre-symptom event monitors makes them ideal for long-term monitoring
TABLE 28 PRE-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 29 PRE-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.6.1.2 Post-symptom event monitors
6.6.1.2.1 The emergence of handheld, wireless, and remote monitors will drive market growth
TABLE 30 POST-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 31 POST-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.6.2 EVENT MONITORS MARKET, BY TECHNOLOGY
6.6.2.1 Autodetect monitors
6.6.2.1.1 Autodetect monitors are ideal for patients who are unable to trigger monitors reliably
6.6.2.2 Manual event monitors
6.6.2.2.1 Manual monitors can be pre-symptom or post-symptom, but rely on the patient to be triggered
6.7 SMART ECG MONITORS
6.7.1 LACK OF DATA SECURITY HINDERS THE GROWTH OF THE SMART MONITORS MARKET TO SOME EXTENT
TABLE 32 INDICATIVE LIST OF SMART ECG MONITORS
TABLE 33 SMART ECG MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 34 SMART ECG MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
6.8 COVID-19 IMPACT ANALYSIS
7 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE (Page No. - 89)
7.1 INTRODUCTION
TABLE 35 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 36 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 37 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2018-2025 (UNITS
7.2 DEFIBRILLATORS
TABLE 38 DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 39 DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 40 DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 41 DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
TABLE 42 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 43 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 44 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 45 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.2.1.1 Transvenous implantable cardioverter defibrillators (T-ICDs
TABLE 46 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 47 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 48 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 49 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.2.1.1.1 Biventricular ICDS/CRT-Ds
7.2.1.1.1.1 Biventricular ICDs/CRT-Ds are preferred for heart failure patients
TABLE 50 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 51 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.2.1.1.2 Dual-chamber ICDs
7.2.1.1.2.1 The benefits of dual-chamber ICDs, such as higher diagnostic accuracy, make them ideal for patients with tachycardia episodes
TABLE 52 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 53 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.2.1.1.3 Single-chamber ICDs
7.2.1.1.3.1 Launch of MRI-compatible single-chamber ICDs will drive market growth
TABLE 54 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 55 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.2.1.2 Subcutaneous implantable cardioverter defibrillators
7.2.1.2.1 Safety and efficacy of S-ICDs in the prevention of sudden cardiac arrest will boost their adoption
TABLE 56 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 57 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.2.2 EXTERNAL DEFIBRILLATORS
TABLE 58 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 59 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
TABLE 60 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 61 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
7.2.2.1 Automated external defibrillators
TABLE 62 INDICATIVE LIST OF AEDS THAT HAVE RECEIVED PREMARKET APPROVAL FROM THE FDA (2018-2019
TABLE 63 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 64 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
TABLE 65 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 66 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
7.2.2.1.1 Semi-automated external defibrillators
7.2.2.1.1.1 Semi-automated external defibrillators accounted for the largest share of the AEDs market in 2018
7.2.2.1.2 Fully automated external defibrillators
7.2.2.1.2.1 Benefits of fully automatic AEDs and higher accuracy will drive market growth
7.2.2.2 Manual external defibrillators
7.2.2.2.1 North America dominates the manual defibrillators market
TABLE 67 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 68 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.2.2.3 Wearable cardioverter defibrillators
7.2.2.3.1 Ease of use and the noninvasive nature of wearable cardioverter defibrillators will support market growth
TABLE 69 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 70 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.3 PACEMAKERS
TABLE 71 PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 72 PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY
TABLE 73 PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 74 PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
7.3.1.1 Implantable pacemakers
7.3.1.1.1 Introduction of leadless and MRI-safe devices has boosted device popularity
TABLE 75 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 76 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.3.1.2 External pacemakers
7.3.1.2.1 Increasing number of open-heart surgeries will drive the demand for external pacemakers
TABLE 77 EXTERNAL PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 78 EXTERNAL PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.3.2 PACEMAKERS MARKET, BY TYPE
TABLE 79 PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 80 PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
7.3.2.1 Dual-chamber pacemakers
7.3.2.1.1 Dual-chamber pacemakers are the most commonly implanted pacemakers for bradycardia
TABLE 81 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 82 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.3.2.2 Single-chamber pacemakers
7.3.2.2.1 Introduction of leadless pacemakers will stimulate demand in this product segment
TABLE 83 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 84 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.3.2.3 Biventricular/CRT pacemakers
7.3.2.3.1 High cost and unfavorable reimbursement scenario have hindered market growth
TABLE 85 BIVENTRICULAR/CRT PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 86 BIVENTRICULAR/CRT PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
7.4 COVID-19 IMPACT ANALYSIS
8 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER (Page No. - 113)
8.1 INTRODUCTION
TABLE 87 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 88 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
8.2 HOSPITALS
8.2.1 GROWING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET GROWTH
TABLE 89 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2016-2019 (USD MILLION)
TABLE 90 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2020-2025 (USD MILLION)
8.3 CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS
8.3.1 GROWING FOCUS ON AMBULATORY CARE IN THE US TO DRIVE THE ADOPTION OF CM & CRM DEVICES
TABLE 91 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2016-2019 (USD MILLION)
TABLE 92 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2020-2025 (USD MILLION)
8.4 OTHER END USERS
TABLE 93 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2016-2019 (USD MILLION)
TABLE 94 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2020-2025 (USD MILLION)
8.5 COVID-19 IMPACT ANALYSIS
9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION (Page No. - 119)
9.1 INTRODUCTION
TABLE 95 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 96 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
TABLE 97 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 98 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
TABLE 99 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
TABLE 100 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
TABLE 101 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 102 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 103 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 104 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 105 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 106 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 107 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 108 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 109 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 110 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 111 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 112 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 113 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 114 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 115 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 116 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 117 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 118 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 119 NORTH AMERICA: T-ICDS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 120 NORTH AMERICA: T-ICDS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 121 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 122 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 123 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 124 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 125 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 126 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 127 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 128 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.2.1 US
9.2.1.1 Growing number of FDA approvals for CM & CRM devices to support market growth in the US
TABLE 129 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 130 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 131 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 132 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 133 US: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 134 US: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 135 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 136 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 137 US: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 138 US: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Growing focus of government and private organizations on providing funding for research to drive market growth
TABLE 139 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 140 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 141 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 142 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 143 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 144 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 145 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 146 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 147 CANADA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 148 CANADA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3 EUROPE
TABLE 149 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 150 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 151 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 152 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 153 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 154 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 155 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 156 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 157 EUROPE: ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 158 EUROPE: ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 159 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 160 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 161 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 162 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 163 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 164 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 165 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 166 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 167 EUROPE: T-ICDS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 168 EUROPE: T-ICDS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 169 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 170 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 171 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 172 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 173 EUROPE: PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 174 EUROPE: PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 175 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 176 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Increasing healthcare expenditure to drive market growth
TABLE 177 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 178 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 179 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 180 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 181 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 182 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 183 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 184 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 185 GERMANY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 186 GERMANY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Rising prevalence of heart failure to drive the adoption of CRT devices in France
FIGURE 21 FRANCE: CRM DEVICE IMPLANTATION, 2015-2018
TABLE 187 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 188 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 189 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 190 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 191 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 192 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 193 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 194 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 195 FRANCE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 196 FRANCE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.3 UK
9.3.3.1 Rising demand for home-based cardiac monitoring devices to support market growth
TABLE 197 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 198 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 199 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 200 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 201 UK: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 202 UK: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 203 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 204 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 205 UK: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 206 UK: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increasing incidence of atrial fibrillation among the elderly will drive market growth in Italy
TABLE 207 ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (THOUSANDS
TABLE 208 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 209 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 210 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 211 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 212 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 213 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 214 ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 215 ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 216 ITALY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 217 ITALY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising awareness and growing device adoption indicate strong growth in the coming years
TABLE 218 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 219 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 220 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 221 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 222 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 223 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 224 SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 225 SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 226 SPAIN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 227 SPAIN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 228 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050
TABLE 229 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 230 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 231 ROE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 232 ROE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 233 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 234 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 235 ROE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 236 ROE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 237 ROE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 238 ROE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
TABLE 239 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 240 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 241 APAC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 242 APAC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 243 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
TABLE 244 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
TABLE 245 APAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 246 APAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 247 APAC: ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 248 APAC: ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 249 APAC: EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 250 APAC: EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 251 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 252 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 253 APAC: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 254 APAC: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 255 APAC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 256 APAC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 257 APAC: T-ICDS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 258 APAC: T-ICDS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 259 APAC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 260 APAC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 261 APAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 262 APAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 263 APAC: PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 264 APAC: PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 265 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 266 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan
FIGURE 23 JAPAN: HEALTH EXPENDITURE AS A SHARE OF GDP, 2005-2017
TABLE 267 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 268 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 269 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 270 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 271 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 272 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 273 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 274 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 275 JAPAN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 276 JAPAN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Rising prevalence of CVDs and government support for infrastructural improvements will drive market growth
TABLE 277 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 278 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 279 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 280 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 281 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 282 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 283 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 284 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 285 CHINA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 286 CHINA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Government initiatives will propel market growth in India
TABLE 287 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 288 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 289 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 290 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 291 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 292 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 293 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 294 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 295 INDIA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 296 INDIA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 297 ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 298 ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 299 ROAPAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 300 ROAPAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 301 ROAPAC: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 302 ROAPAC: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 303 ROAPAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 304 ROAPAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 305 ROAPAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 306 ROAPAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 307 ROW: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 308 ROW: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 309 ROW: ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 310 ROW: ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 311 ROW: EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 312 ROW: EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 313 ROW: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 314 ROW: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 315 ROW: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 316 ROW: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 317 ROW: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 318 ROW: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 319 ROW: T-ICDS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 320 ROW: T-ICDS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 321 ROW: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 322 ROW: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 323 ROW: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
TABLE 324 ROW: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
TABLE 325 ROW: PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
TABLE 326 ROW: PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
TABLE 327 ROW: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
TABLE 328 ROW: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 198)
10.1 OVERVIEW
FIGURE 24 KEY DEVELOPMENTS IN THE CM & CRM DEVICES MARKET, JANUARY 2017-JULY 2020
FIGURE 25 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO JULY 2020
10.2 COMPETITIVE SCENARIO
10.2.1 PRODUCT LAUNCHES & APPROVALS
TABLE 329 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2017?JULY 2020
10.2.2 AGREEMENTS, CONTRACTS, COLLABORATIONS, AND PARTNERSHIPS
TABLE 330 KEY AGREEMENTS, CONTRACTS, COLLABORATIONS, AND PARTNERSHIPS, JANUARY 2017?JULY 2020
10.2.3 ACQUISITIONS
TABLE 331 KEY ACQUISITIONS, JANUARY 2017?JULY 2020
10.2.4 EXPANSIONS
TABLE 332 KEY EXPANSIONS, JANUARY 2017?JULY 2020
11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 204)
11.1 COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
11.1.1 MARKET SHARE ANALYSIS, 2019
FIGURE 26 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS, 2019
11.2 COMPANY EVALUATION MATRIX
11.2.1 STARS
11.2.2 EMERGING LEADERS
11.2.3 PERVASIVE
11.2.4 PARTICIPANTS
FIGURE 27 VENDOR DIVE: CM & CRM DEVICES MARKET
11.3 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
11.3.1 PROGRESSIVE COMPANIES
11.3.2 STARTING BLOCKS
11.3.3 RESPONSIVE COMPANIES
11.3.4 DYNAMIC COMPANIES
FIGURE 28 VENDOR DIVE MATRIX FOR START-UPS: CM & CRM DEVICES MARKET
11.4 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.4.1 ABBOTT LABORATORIES
FIGURE 29 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
11.4.2 MEDTRONIC PLC
FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
11.4.3 BOSTON SCIENTIFIC CORPORATION
FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
11.4.4 GE HEALTHCARE
FIGURE 32 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
11.4.5 KONINKLIJKE PHILIPS N.V.
FIGURE 33 PHILIPS: COMPANY SNAPSHOT (2019)
11.4.6 BIOTRONIK
11.4.7 ASAHI KASEI CORPORATION
FIGURE 34 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2019)
11.4.8 MICROPORT SCIENTIFIC CORPORATION
FIGURE 35 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
11.4.9 HILL-ROM HOLDINGS, INC.
FIGURE 36 HILL-ROM HOLDINGS: COMPANY SNAPSHOT (2019)
11.4.10 NIHON KOHDEN CORPORATION
FIGURE 37 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2019)
11.4.11 SCHILLER AG
11.4.12 BIOTELEMETRY
FIGURE 38 BIOTELEMETRY: COMPANY SNAPSHOT (2019)
11.4.13 ACS DIAGNOSTICS
11.4.14 BPL MEDICAL TECHNOLOGIES
11.4.15 BTL
11.4.16 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
11.4.17 LEPU MEDICAL TECHNOLOGY
FIGURE 39 LEPU MEDICAL TECHNOLOGY: COMPANY SNAPSHOT (2016)
11.4.18 SHREE PACETRONIX
FIGURE 40 SHREE PACETRONIX: COMPANY SNAPSHOT (2017)
11.4.19 OSYPKA AG
11.4.20 ALIVECOR, INC.
11.4.21 AMIITALIA
11.4.22 BEXEN CARDIO
11.4.23 NARANG MEDICAL LIMITED
11.4.24 METRAX GMBH
11.4.25 PROGETTI SRL
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 ADJACENT MARKETS (Page No. - 251)
12.1 INTRODUCTION
12.2 RESUSCITATION DEVICES MARKET
12.2.1 MARKET DEFINITION
12.2.2 MARKET OVERVIEW
12.2.2.1 Driver: High demand for emergency care
12.3 RESUSCITATION DEVICES MARKET, BY PRODUCT
TABLE 333 RESUSCITATION DEVICES MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
12.4 RESUSCITATION DEVICES MARKET, BY PATIENT TYPE
TABLE 334 RESUSCITATION DEVICES MARKET, BY PATIENT TYPE, 2018-2025 (USD MILLION)
12.5 RESUSCITATION DEVICES MARKET, BY END USER
TABLE 335 RESUSCITATION DEVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
12.6 RESUSCITATION DEVICES MARKET, BY REGION
TABLE 336 RESUSCITATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
13 APPENDIX (Page No. - 256)
13.1 INDUSTRY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.4 AVAILABLE CUSTOMIZATIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
The study involved four major activities to estimate the current size of the cardiac monitoring & cardiac rhythm management devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for this study.
Primary Research
Several stakeholders such as cardiac monitoring & cardiac rhythm management devices manufacturers, vendors, distributors, researchers, and doctors from hospitals and clinics were consulted for this report. The demand side of this market is characterized by significant use of cardiac monitoring & cardiac rhythm management devices due to increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; and the growing preference for wearable cardiac devices. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
BREAKDOWN OF PRIMARY PARTICIPANTS:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac monitoring & cardiac rhythm management devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the cardiac monitoring & cardiac rhythm management devices industry.
Report Objectives
- To define, describe, and forecast the cardiac monitoring & cardiac rhythm management devices market on the basis of cardiac monitoring devices by type, cardiac rhythm management devices by type, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, and opportunities, Covid-19 Impact Analysis)
- To strategically analyse micromarkets with respect to individual growth trends, prospects, and contributions to the overall cardiac monitoring & cardiac rhythm management devices market
- To analyse market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments in five geographical regions, namely, North America, Europe, the Asia Pacific, Latin America, and Rest of the World.
- To profile the key players and comprehensively analyse their product portfolios, market positions, and core competencies.
- To track and analyse competitive developments such as product launches and approvals, partnerships, expansions, and acquisitions in the cardiac monitoring & cardiac rhythm management devices market
Available Customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis:
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the European, Asia Pacific, and Rest of the World segments into their respective countries for this market
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Opportunities Assessment
- A detailed report underlining the various growth opportunities presented in the market
Generating Response ...
Growth opportunities and latent adjacency in Cardiac Monitoring & Cardiac Rhythm Management Devices Market